Appendix 1.
Author disclosure table
| Writing group member | Employment | Honoraria/speaking/consulting | Speakers’ bureau | Research∗ | Fellowship support∗ | Ownership/partnership/principal/majority stockholder | Stock or stock options | Intellectual property/royalties | Other |
|---|---|---|---|---|---|---|---|---|---|
| Dhanunjaya R. Lakkireddy, MD, FHRS (Co-Chair) | Kansas City Heart Rhythm Institute and Research Foundation, Overland Park, Kansas | 1: BIOTRONIK; 2: Abbott | 1: Abiomed; 1: Biosense Webster; 1: Boston Scientific;2: Janssen | None | None | None | None | None | None |
| Mina K. Chung, MD, FHRS (Co-Chair) | Heart, Vascular, and Thoracic Institute and Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio | 2: ABIM | None | 5: AHA; 5: NIH | None | None | None | 1: Elsevier; 1: UpToDate | 0: AHA (Chair, ECG & Arrhythmias Committee; Member, Clinical Cardiology Leadership Committee; Member, Committee on Scientific Sessions Programming); 0: Amarin (Data Monitoring Committee Member); 2: AHA (Associate Editor, Circulation: Arrhythmia and Electrophysiology) |
| Christine M. Albert, MD, MPH, FHRS | Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California | None | None | 5: Abbott; 5: NIH; 5: Roche Diagnostics | None | None | None | None | None |
| Thomas F. Deering, MD, MBA, FHRS | Piedmont Heart Institute, Atlanta, Georgia | 1: Abbott (Adjudication Committee for IDE Trial) | None | 0: Abbott; 0:BIOTRONIK; 0: Boston Scientific; 0:CVRx, Inc.; 0: HUYA Bioscience International; 0: Medtronic; 0: Milestone | None | None | None | None | 0: EHRA (Speaker at annual Scientific Sessions); 0: ACC (Speaker at annual Scientific Sessions & other meetings); 0: HRS (Past President) |
| Laurence M. Epstein, MD | Northwell Health, Manhasset, New York | 1: Abbott; 2: Medtronic; 2: Spectranetics Corporation | None | None | None | None | None | None | 2: Boston Scientific (Clinical Events Committee) |
| Rakesh Gopinathannair, MD, MA, FHRS | Kansas City Heart Rhythm Institute and Research Foundation, Overland Park, Kansas | 1: Abbott; 1: Boston Scientific; 1:ZOLL Medical Corporation | 1: Pfizer | None | None | None | None | None | 0: AltaThera Pharmaceuticals (Physician Advisor) |
| Clifford V. Harding, MD, PhD | Case Western Reserve University, Cleveland, Ohio | None | None | 4: NIH | None | None | None | None | None |
| Jodie L. Hurwitz, MD, FHRS | North Texas Heart Center, Dallas, Texas | 1: Medtronic | None | None | None | None | 3: Microsoft | None | 1: ABIM (CCEP Writing Committee Member) |
| Courtney C. Jeffery, MSN, APRN-C | Kansas City Heart Rhythm Institute and Research Foundation, Overland Park, Kansas | 1: Abbott; 1: Medtronic | None | None | None | None | None | None | None |
| Andrew D. Krahn, MD, FHRS | University of British Columbia, Vancouver, British Columbia, Canada | 1: Medtronic | None | None | None | None | None | None | None |
| Fred M. Kusumoto, MD, FHRS | Mayo Clinic Jacksonville, Jacksonville, Florida | None | None | None | None | None | None | None | None |
| Rachel Lampert, MD, FHRS | Yale School of Medicine, New Haven, Connecticut | 1: Abbott; 1: Medtronic | None | 0: Amgen; 0: MediLynx;2: Abbott; 2: Medtronic | None | None | None | None | None |
| Moussa Mansour, MD, FHRS | Massachusetts General Hospital, Boston, Massachusetts | 1: Abbott; 1: Biosense Webster; 1: Boston Scientific; 1: Medtronic | None | 0: Abbott; 0: Biosense Webster | None | None | 5: NewPace Ltd; 5: EPD Solutions | None | None |
| Andrea Natale, MD, FHRS | Texas Cardiac Arrhythmia Institute, Austin, Texas | 1: Baylis Medical Company; 1: BIOTRONIK; 1: Boston Scientific; 1: Medtronic; 2: Abbott; 2: Biosense Webster | None | None | None | None | None | None | None |
| Kristen K. Patton, MD, FHRS | University of Washington, Seattle, Washington | None | None | None | None | None | None | None | 0: ACGME RC Internal Medicine; 0: AHA Clinical Cardiology Council; 0: ACC EP Council (Committee Member); 1: FDA Circulatory System Devices Panel; 1: ABIM |
| Andrea M. Russo, MD, FHRS | Cooper Medical School of Rowan University, Camden, New Jersey | None | None | 1: MediLynx; 2: Boston Scientific | None | None | None | 1: UpToDate | 0: ABIM (Member, ABIM Cardiovascular Board); 0: Apple Inc. (Steering Committee, Apple Heart Study); 0: Boston Scientific (Steering Committee, Research) |
| Amber Seiler, ANP, FHRS | Cone Health, Greensboro, North Carolina | 1: Biosense Webster; 2: Medtronic | None | None | None | 3: CV Remote Solutions | None | None | None |
| Maully J. Shah, MBBS, FHRS | Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania | 0: Medtronic | None | None | None | None | None | None | 0: SADS Foundation (Board Member); 1: JACC (Associate Editor) |
| Paul J. Wang, MD, FHRS | Stanford University, Palo Alto, California | None | None | 5: AHA; 5: Coulter Foundation | None | None | None | None | None |
Number value: 0 = $0; 1 = ≤$10,000; 2 = >$10,000 to ≤$25,000; 3 = >$25,000 to ≤$50,000; 4 = >$50,000 to ≤$100,000; 5 = >$100,000.
ABIM = American Board of Internal Medicine; ACC = American College of Cardiology; ACGME = Accreditation Council for Graduate Medical Education; AHA = American Heart Association; CCEP = Clinical Cardiac Electrophysiology; EHRA = European Heart Rhythm Association; EP = electrophysiology; FDA = Food and Drug Administration; HRS = Heart Rhythm Society; JACC = Journal of the American College of Cardiology; NIH = National Institutes of Health; RC = Review Committee; SADS = Sudden Arrhythmia Death Syndromes.
∗
Research and fellowship support are classed as programmatic support. Sources of programmatic support are disclosed but are not regarded as a relevant relationship with industry for writing group members or reviewers.